TP53 and liver cancer: Here, we show that HELLS represents a strong P53 repression target in liver cancer by a mechanism involving the cyclin-dependent kinase inhibitor P21/CDKN1A and the transcription factor Forkhead Box Protein M1 (FOXM1).